Lilly’s partnership with Indian drugmakers will expand access to Covid-19 treatment
The pacts will increase the availability of baricitinib in India as it battles a catastrophic second wave of coronavirus.
Markets
Pfizer forecasts $26bn of Covid-19 vaccine revenue after first-quarter success
According to the first-quarter results published by Pfizer this week, its coronavirus jab has reaped...
NICE: the five-year plan to improve patients’ access to innovative treatments
The UK’s National Institute of Health and Care Excellence (NICE) has launched an ambitious five-year strategy to speed up patients’...
Global rheumatologists’ biosimilar prescription rates shift from 2018 to 2020
The rate of biosimilar adoption for the treatment of autoimmune diseases varies greatly by geographical market.
Science park merger creates UK’s largest life sciences ecosystem
Three companies have merged to form the UK’s first nationwide life sciences ecosystem, boosting R&D and drug discovery capacity in...
Antibiotic resistance: how Covid-19 could be accelerating the ‘silent pandemic’
Long before the outbreak of Covid-19, another health emergency has posed a threat to life as we know it. Antibiotic resistance, which occurs when bacterial infections cease to respond to…
Covishield: India’s vaccine giant struggles to deliver as local cases surge
The world’s biggest vaccine producer has found itself under growing pressure to meet global Covid-19 jab delivery targets, after export restrictions were imposed by the Indian government in response to…
AZ’s proposed acquisition of rare disease-focused Alexion gets US clearance
AstraZeneca’s proposed $39bn acquisition of rare disease therapy company Alexion Pharmaceuticals has passed a US Federal Trade Commission (FTC) review. Cambridge-based AstraZeneca (AZ) first announced its intention to buy out…
Ivermectin and Covid-19: how a cheap antiparasitic became political
In the year since the Covid-19 pandemic began, various unconventional treatments have been hailed as potential cures for the respiratory virus that has so far claimed over three million lives…
Post-Brexit point-based immigration system will affect the UK’s healthcare system: Poll
The UK government commenced taking applications for the new Skilled Worker Visa from January 2021, based on the new post-Brexit points-based visa and immigration system. Verdict conducted a poll to…
Cell and gene therapy: the impact of skills gaps in a fast-growing sector
Cell and gene therapy (CGT) is an experimental space that has grown exponentially in recent years; the sector received nearly $20bn in funding last year, a 50% increase on the…
